168 related articles for article (PubMed ID: 17406612)
21. A HTRF based competitive binding assay for screening specific inhibitors of HIV-1 capsid assembly targeting the C-Terminal domain of capsid.
Zhang DW; Luo RH; Xu L; Yang LM; Xu XS; Bedwell GJ; Engelman AN; Zheng YT; Chang S
Antiviral Res; 2019 Sep; 169():104544. PubMed ID: 31254557
[TBL] [Abstract][Full Text] [Related]
22. Trapping of hepatitis B virus capsid assembly intermediates by phenylpropenamide assembly accelerators.
Katen SP; Chirapu SR; Finn MG; Zlotnick A
ACS Chem Biol; 2010 Dec; 5(12):1125-36. PubMed ID: 20845949
[TBL] [Abstract][Full Text] [Related]
23. Reactive oxygen species promote heat shock protein 90-mediated HBV capsid assembly.
Kim YS; Seo HW; Jung G
Biochem Biophys Res Commun; 2015 Feb; 457(3):328-33. PubMed ID: 25576869
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and Evaluation of N-Phenyl-3-sulfamoyl-benzamide Derivatives as Capsid Assembly Modulators Inhibiting Hepatitis B Virus (HBV).
Vandyck K; Rombouts G; Stoops B; Tahri A; Vos A; Verschueren W; Wu Y; Yang J; Hou F; Huang B; Vergauwen K; Dehertogh P; Berke JM; Raboisson P
J Med Chem; 2018 Jul; 61(14):6247-6260. PubMed ID: 29906396
[TBL] [Abstract][Full Text] [Related]
25. Zinc ions trigger conformational change and oligomerization of hepatitis B virus capsid protein.
Stray SJ; Ceres P; Zlotnick A
Biochemistry; 2004 Aug; 43(31):9989-98. PubMed ID: 15287726
[TBL] [Abstract][Full Text] [Related]
26. Identification of Factors Promoting HBV Capsid Self-Assembly by Assembly-Promoting Antivirals.
Rath SL; Liu H; Okazaki S; Shinoda W
J Chem Inf Model; 2018 Feb; 58(2):328-337. PubMed ID: 29309148
[TBL] [Abstract][Full Text] [Related]
27. The novel compound Z060228 inhibits assembly of the HBV capsid.
Guan H; Zhao G; Chen W; Wu G; Liu H; Jiang X; Li S; Wang LL
Life Sci; 2015 Jul; 133():1-7. PubMed ID: 25921762
[TBL] [Abstract][Full Text] [Related]
28. Targeting the Early Step of Building Block Organization in Viral Capsid Assembly.
Lampel A; Bram Y; Ezer A; Shaltiel-Kario R; Saad JS; Bacharach E; Gazit E
ACS Chem Biol; 2015 Aug; 10(8):1785-90. PubMed ID: 25997366
[TBL] [Abstract][Full Text] [Related]
29. Molecular mechanisms of tetrahydropyrrolo[1,2-c]pyrimidines as HBV capsid assembly inhibitors.
Song LT; Liu RR; Zhai HL; Meng YJ; Zhu M
Arch Biochem Biophys; 2019 Mar; 663():1-10. PubMed ID: 30593769
[TBL] [Abstract][Full Text] [Related]
30. Viral structural proteins as targets for antivirals.
Schlicksup CJ; Zlotnick A
Curr Opin Virol; 2020 Dec; 45():43-50. PubMed ID: 32777753
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of virus assembly.
Perlmutter JD; Hagan MF
Annu Rev Phys Chem; 2015 Apr; 66():217-39. PubMed ID: 25532951
[TBL] [Abstract][Full Text] [Related]
32. Development of novel hepatitis B virus capsid inhibitor using in silico screening.
Hayakawa M; Umeyama H; Iwadate M; Tanahashi T; Yano Y; Enomoto M; Tamori A; Kawada N; Murakami Y
Biochem Biophys Res Commun; 2015 Aug; 463(4):1165-75. PubMed ID: 26095852
[TBL] [Abstract][Full Text] [Related]
33. A theoretical model successfully identifies features of hepatitis B virus capsid assembly.
Zlotnick A; Johnson JM; Wingfield PW; Stahl SJ; Endres D
Biochemistry; 1999 Nov; 38(44):14644-52. PubMed ID: 10545189
[TBL] [Abstract][Full Text] [Related]
34. A new series of HAPs as anti-HBV agents targeting at capsid assembly.
Yang XY; Xu XQ; Guan H; Wang LL; Wu Q; Zhao GM; Li S
Bioorg Med Chem Lett; 2014 Sep; 24(17):4247-9. PubMed ID: 25127104
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids.
Deres K; Schröder CH; Paessens A; Goldmann S; Hacker HJ; Weber O; Krämer T; Niewöhner U; Pleiss U; Stoltefuss J; Graef E; Koletzki D; Masantschek RN; Reimann A; Jaeger R; Gross R; Beckermann B; Schlemmer KH; Haebich D; Rübsamen-Waigmann H
Science; 2003 Feb; 299(5608):893-6. PubMed ID: 12574631
[TBL] [Abstract][Full Text] [Related]
36. Capsid assembly as a point of intervention for novel anti-viral therapeutics.
Lingappa VR; Hurt CR; Garvey E
Curr Pharm Biotechnol; 2013; 14(5):513-23. PubMed ID: 22429134
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of hepatitis B virus replication by the internal fragment of hepatitis B core protein.
Han J; Pan X; Gao Y; Weil L
Virus Res; 2010 Jun; 150(1-2):129-34. PubMed ID: 20303370
[TBL] [Abstract][Full Text] [Related]
38. Classical nucleation theory of virus capsids.
Zandi R; van der Schoot P; Reguera D; Kegel W; Reiss H
Biophys J; 2006 Mar; 90(6):1939-48. PubMed ID: 16387781
[TBL] [Abstract][Full Text] [Related]
39. Benzimidazole derivative, BM601, a novel inhibitor of hepatitis B virus and HBsAg secretion.
Xu YB; Yang L; Wang GF; Tong XK; Wang YJ; Yu Y; Jing JF; Feng CL; He PL; Lu W; Tang W; Zuo JP
Antiviral Res; 2014 Jul; 107():6-15. PubMed ID: 24746457
[TBL] [Abstract][Full Text] [Related]
40. Structure, assembly, and antigenicity of hepatitis B virus capsid proteins.
Steven AC; Conway JF; Cheng N; Watts NR; Belnap DM; Harris A; Stahl SJ; Wingfield PT
Adv Virus Res; 2005; 64():125-64. PubMed ID: 16139594
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
